Metabolon

About:

Metabolon offers metabolomics solutions that enhance life sciences research, diagnostics, and precision medicine.

Website: https://www.metabolon.com

Twitter/X: Metabolon

Top Investors: Trinity Capital, Perceptive Advisors, National Institutes of Health, Alexandria Real Estate Equities, Fulcrum Equity Partners

Description:

Metabolon is a technology company, that develops analytical methods and software for biomarker discovery using metabolomics. Metabolon's expertise in data and translational science enables customers and partners to tackle some of the most complex and urgent questions in the life sciences, thereby accelerating research and improving development outcomes. The company provides scalable and customizable multiomics solutions, including metabolomics and lipidomics, to support customer needs from discovery through clinical trials and throughout the product lifecycle. The company aims to provide biochemical data and insights that broaden and hasten the impact of life sciences research, while also integrating seamlessly with other 'omics' technologies.

Total Funding Amount:

$260M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Morrisville, North Carolina, United States

Founded Date:

2000-01-01

Contact Email:

info(AT)metabolon.com

Founders:

John Ryals, Paul Schimmel

Number of Employees:

251-500

Last Funding Date:

2024-06-25

IPO Status:

Private

Industries:

© 2025 bioDAO.ai